Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
MediWound Ltd. - Ordinary Shares
(NQ:
MDWD
)
13.73
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 3, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
204
Open
13.73
Bid (Size)
13.59 (100)
Ask (Size)
14.15 (100)
Prev. Close
13.73
Today's Range
13.73 - 13.73
52wk Range
13.54 - 22.48
Shares Outstanding
27,272,818
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
MediWound (MDWD) Q1 2026 Earnings Transcript
↗
May 27, 2026
MediWound (MDWD) Q1 2026 Earnings Transcript
Via
The Motley Fool
MediWound Q1 Earnings Call Highlights
↗
May 27, 2026
MediWound (NASDAQ:MDWD) reported a wider first-quarter loss and lower revenue compared with the prior-year period, while management reaffirmed its 2026 revenue outlook and said it continued to advance...
Via
MarketBeat
Topics
Earnings
Performance
YTD
-25.5%
-25.5%
1 Month
-20.5%
-20.5%
3 Month
-22.0%
-22.0%
6 Month
-22.5%
-22.5%
1 Year
-36.4%
-36.4%
More News
Read More
MediWound Ltd. (NASDAQ:MDWD) Q1 2026: Revenue Miss but Narrower Loss, Full-Year Outlook Intact
↗
May 27, 2026
Via
Chartmill
MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 27, 2026
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Ltd. (NASDAQ:MDWD) Reports Q4 2025 Revenue Miss Despite Pipeline Progress
↗
March 05, 2026
Via
Chartmill
MediWound to Report First Quarter 2026 Financial Results
May 07, 2026
From
MediWound Ltd.
Via
GlobeNewswire
Newly Published U.S. Expert Consensus Aligns with MediWound’s Strategy for Chronic Wound Debridement
April 13, 2026
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Present New EscharEx® Data at Leading Wound Care Conferences
April 07, 2026
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million
April 02, 2026
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Files Annual Report on Form 20-F
March 05, 2026
From
MediWound Ltd.
Via
GlobeNewswire
MediWound (MDWD) Q4 2025 Earnings Call Transcript
↗
March 05, 2026
Via
The Motley Fool
Topics
Earnings
MediWound Reports Fourth Quarter and Full Year 2025 Financial Results
March 05, 2026
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Report Fourth Quarter and Full Year 2025 Financial Results
February 19, 2026
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Present at Upcoming Investor Conferences
February 17, 2026
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference
January 12, 2026
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Reports New Clinical Data Demonstrating NexoBrid®’s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries
December 10, 2025
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Ltd (NASDAQ:MDWD) Reports Q3 2025 Earnings: Revenue Misses, EPS Beats Estimates
↗
November 20, 2025
Via
Chartmill
MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 20, 2025
From
MediWound Ltd.
Via
GlobeNewswire
Examining the Future: MediWound's Earnings Outlook
↗
November 19, 2025
Via
Benzinga
MediWound to Report Third Quarter 2025 Financial Results
November 05, 2025
From
MediWound Ltd.
Via
GlobeNewswire
Earnings Scheduled For November 20, 2025
↗
November 20, 2025
Via
Benzinga
MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid®
November 03, 2025
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares
September 29, 2025
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Expands Global Reach with Marketing Approval of NexoBrid® in Australia
September 25, 2025
From
MediWound Ltd.
Via
GlobeNewswire
MediWound’s NexoBrid® to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress
September 02, 2025
From
MediWound Ltd.
Via
GlobeNewswire
Frequently Asked Questions
Is MediWound Ltd. - Ordinary Shares publicly traded?
Yes, MediWound Ltd. - Ordinary Shares is publicly traded.
What exchange does MediWound Ltd. - Ordinary Shares trade on?
MediWound Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for MediWound Ltd. - Ordinary Shares?
The ticker symbol for MediWound Ltd. - Ordinary Shares is MDWD on the Nasdaq Stock Market
What is the current price of MediWound Ltd. - Ordinary Shares?
The current price of MediWound Ltd. - Ordinary Shares is 13.73
When was MediWound Ltd. - Ordinary Shares last traded?
The last trade of MediWound Ltd. - Ordinary Shares was at 06/03/26 04:00 PM ET
What is the market capitalization of MediWound Ltd. - Ordinary Shares?
The market capitalization of MediWound Ltd. - Ordinary Shares is 374.46M
How many shares of MediWound Ltd. - Ordinary Shares are outstanding?
MediWound Ltd. - Ordinary Shares has 374M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
